Veri

Based in Finland, Veri specializes in personalized metabolic health solutions that empower users to optimize their health through advanced monitoring of blood sugar levels and tailored dietary recommendations. Founded in 2019 in Helsinki, Finland, Veri develops innovative health technology aimed at enhancing metabolic health. The company has successfully raised a total of EUR 3. 30 mn through Seed funding led by PROfounders Capital, with additional investments from Accel and Lifeline Ventures.

The latest funding round occurred in September 2024, on the same date that Oura Health Ltd. acquired Veri to bolster its metabolic health offerings. Founders Anttoni Aniebonam and Verneri Jaamuru have a background in health technology, positioning them as suitable leaders in this sector. Veri offers a personalized metabolic health program primarily aimed at helping individuals optimize their health by managing their blood sugar levels.

The core product is a mobile application integrated with continuous glucose monitors (CGMs) such as the Libre 14-day system, Libre 2, and Libre 3. The app allows users to monitor their glucose levels in real-time via Bluetooth without needing finger pricks. It leverages artificial intelligence to log meals through photos and translate glucose data into actionable insights and dietary recommendations, targeting users in the United States with metabolic conditions like insulin resistance and pre-diabetes. In 2023, Veri reported a revenue of EUR 5,341,938.

10 and an EBITDA of EUR -2,731,139. 00. The company utilizes a subscription-based model, providing users with ongoing access to its app features, including real-time glucose monitoring and personalized dietary insights, critical for improving health outcomes. Following the acquisition by Oura Health Ltd.

in September 2024, Veri plans to enhance its product offerings and expand its market reach. The integration aims to leverage Oura's existing customer base to promote Veri's metabolic health solutions. The recent funding will support the development of new features and potential expansion into additional markets, though specific timelines for these initiatives have yet to be disclosed.